US patent allowance crucial to $566 million Aveo Oncology buyout
Success at the USPTO clinched a premium-price acquisition for the oncology innovator
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.